1. Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma
   Ryan A. Lacinski et al, 2024, Frontiers in Oncology CrossRef
2. Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction
   Nutnicha Sirikaew et al, 2022, International Journal of Molecular Sciences CrossRef
3. Gene signatures with predictive and prognostic survival values in human osteosarcoma
   Zhongpeng Qiu et al, 2021, PeerJ CrossRef
4. Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
   Yoshiyuki Suehara et al, 2012, Sarcoma CrossRef
5. The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
   Yujing Huang et al, 2021, OncoTargets and Therapy CrossRef